Dr Lal Path Labs jumps over 7% after Q1 earnings beat; Nomura raises target price to Rs 2,085

Dr Lal Path Labs reported 28.02% year-on-year rise in consolidated net profit to Rs 169.5 crore for Q1 FY27.

Net profit was Rs 132.4 crore a year ago.

Shares jumped over 7% after Q1 earnings beat.

Nomura raised target price to Rs 2,085.